LINC00978 Promotes Hepatocellular Carcinoma Carcinogenesis Partly via Activating the MAPK/ERK Pathway

Bioscience Reports - Netherlands
doi 10.1042/bsr20192790
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Portland Press Ltd.

Related search

Novel 2-Phenyloxypyrimidine Derivative Induces Apoptosis and Autophagy via Inhibiting PI3K Pathway and Activating MAPK/ERK Signaling in Hepatocellular Carcinoma Cells

Scientific Reports
Multidisciplinary
2018English

Long Non‑coding RNA Igf2as Controls Hepatocellular Carcinoma Progression Through the ERK/MAPK Signaling Pathway

Oncology Letters
Cancer ResearchOncology
2017English

Lack of Hepatic Stimulator Substance Expression Promotes Hepatocellular Carcinoma Metastasis Partly Through ERK-activated Epithelial–mesenchymal Transition

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2018English

JMJD6 Promotes Hepatocellular Carcinoma Carcinogenesis by Targeting CDK4

International Journal of Cancer
Cancer ResearchOncology
2018English

Glypican-3 Promotes Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells Through ERK Signaling Pathway

International Journal of Oncology
Cancer ResearchOncology
2015English

Cullin7 Promotes Epithelial‑mesenchymal Transition of Esophageal Carcinoma via the ERK‑SNAI2 Signaling Pathway

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2018English

KRAS Promotes Tumor Metastasis and Chemoresistance by Repressing RKIP via the MAPK-ERK Pathway in Pancreatic Cancer

International Journal of Cancer
Cancer ResearchOncology
2018English

Shp2 SUMOylation Promotes ERK Activation and Hepatocellular Carcinoma Development

Oncotarget
Oncology
2015English

Targeting the Ras/Raf/Mek/Erk Pathway in Hepatocellular Carcinoma (Review)

Oncology Letters
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy